At BI X, we turn the unknown into clarity. By asking the right questions early, experimenting with purpose, and uncovering opportunities, we uncover where digital innovation can make a meaningful difference for human and animal health. Welcome to BI X.
Across Boehringer Ingelheim, new challenges emerge every day — and with them, opportunities to rethink how digital solutions can support scientific work, operational excellence, and patient impact. As Boehringer Ingelheim’s digital innovation lab, BI X identifies critical problems along the entire pharma value chain, explores potential digital solution, tests assumptions early, and validates what creates real value.
Learn moreBI X operates from Ingelheim, Shanghai, and Ridgefield — connecting diverse perspectives, regional strengths, and global ambition. Across these locations, our teams collaborate closely: transparent, cross-functional, and fast. We share insights early and align on what creates impact. Wherever we are, we’re guided by one purpose: enabling digital innovation that impacts human and animal health.
Whether your idea is just emerging or already taking shape Synapse offers a clear, hands-on process to explore its potential. We believe innovation grows stronger when built together. Synapse is where that starts.
Sharpen the direction and uncover what's worth testing.
Together with BI X experts and Boehringer stakeholders, we assess feasibility, desirability, and business relevance.
When the fit is right, we validate and develop the idea further within the Boehringer ecosystem.




